Accueil Ernstrade Bourse Actualite Stock



Acuvax Limited is an Australia-based holding company. The Company is engaged in the research and development of cancer therapies and virus and vaccine development. The Company is engaged in oncology drug research and development in two geographical segments: Australia and the United States. As of June 30, 2010, Acuvax had a 28% ownership in Hawaii Biotech Inc. (HBI). The principal activity of HBI is the development of preventative or prophylactic vaccines for infectious diseases, such as West Nile virus and dengue fever. The Company’s wholly owned subsidiaries include ACT (USA), Inc., Inqbate Pty Ltd and AL Holdings, Inc.
320 Adelaide Street GPO Box 111
Brisbane, QLD 4001
+61-07-30109442 (Phone)
+61-07-30109001 (Fax)


Copyright  2012